A Clinical Risk Case Study- Preventing Phlebitis Through Correct Cannula Monitoring

A Clinical Risk Case Study- Preventing Phlebitis Through Correct Cannula Monitoring

Setting the Scene

The patient, in this case, was a young child who had a cannula placed at 10:40 am. This cannula was not reviewed until the next day at 6:00 pm when it was flushed and a visual infusion phlebitis score was documented as zero. The child’s father noticed the arm was swollen several days later, at which point the cannula was removed. An ultrasound scan was then performed which showed acute thrombus of the left antecubital and basilica veins.

The main learning points from this review stem from the following events:

  • Not reviewing the cannula at regular intervals
  • Not flushing the cannula adequately, as per Trust protocol
  • No discussions took place between the nursing team and the lead consultant on the ward regarding the need for the cannula

Recommendations to Prevent Incident Recurrence and Improve Patient Safety

TMLEP’s recommendations to reduce recurrence and enhance patient safety are as follows:

  • Ensure cannulas are monitored three times per day, ideally morning, afternoon and night. There should be a visual check completed of the insertion site by removing any bandages that may be covering the cannula. This provides the opportunity to identify any concerns with the cannula such as swelling, redness and pain that may be indicative of phlebitis. Visual phlebitis scores should be documented at each check of the cannula. Phlebitis is the inflammation of a vein and signs to be aware of are localised redness, heat and swelling. It is important to document phlebitis scores, as if phlebitis is left untreated, it can develop into infection, either localised to the cannula site or a more serious bloodstream infection causing sepsis

  • If the cannula is not being used for medications or infusions, it should be flushed with 0.9% saline at each check to ensure patency. (6.2; RCN Guidance 2016). Failing to do so can lead to pain for the patient, as well as inflammation and infection, since it is a device that is ‘foreign’ to the body

  • If the cannula is not flushed regularly it can become blocked, therefore requiring removal and insertion of a new cannula, which is not a good patient experience and can cause trauma to the patient

  • Assess the need for a cannula frequently. This should be discussed on a daily basis and the reason for it remaining documented in the medical notes, as any peripheral vascular device is an infection risk and should be removed if not required

To Summarise

It is the role of the nurse looking after the patient to ensure that the patency of the cannula is maintained by following local policy and best practice guidance. To maintain patency of the cannula, flushing either ‘routinely’ (Parker 2002), daily (RCN 2005c) or eight hourly (Fuller and Winn 1998), has been recommended for peripheral devices. By maintaining the patency of the cannula and carrying out visual checks, this will lead to there being a decreased chance of inflammation and infection occurring.

References

  • ‘Standards for infusion therapy’ Royal College of Nursing 2016 https://www.rcn.org.uk/-/media/royal-college-of-nursing/documents/.../005704.pdf
  • Department of Health (2005) Saving Lives: A Delivery Programme to Reduce Healthcare Associated Infection (HCAI) Including MRSA. The Stationery Office, London.
  • Nursing and Midwifery Council (2018) Professional standards of practice and behaviour for nurses, midwives and nursing associates. NMC, London.
  • Co-written by The TMLEP Clinical Risk and Patient Safety Publishing Group and Ms Vikki Stone, Advanced Diploma in Children’s Nursing; Paediatric Matron (2019). A Clinical Risk Case Study- Preventing Phlebitis Through Correct Cannula Monitoring. TMLEP Clinical Risk Case Studies. 3 (2), 1.

Important Note

This article is intended to raise awareness to clinical risk issues in an effort to reduce incidence recurrence and improve patient safety. This is not intended to be relied upon as advice. Facts have been altered to ensure this case is non-identifiable, albeit clinical learning points remain applicable. To request an independent clinical review, please contact admin@tmlep.com or call +44 (0) 203 355 9796.